Baron Discovery Fund Q1 2026: Who Moved The Needle

The key read-through is not that software was weak, but that capital is continuing to migrate toward names with visible, near-term end-market leverage and away from “good company, average setup” software. AEIS is benefiting from a rerating of its semiconductor/data-center exposure, which matters because these pockets tend to command a higher multiple when investors believe demand is tied to infrastructure buildouts rather than discretionary IT budgets. That makes AEIS less a cyclical beneficiary and more a leverage play on capex durability over the next 2-3 quarters.

INTA’s sale is more interesting as a signal than as a standalone event: when a disciplined growth manager exits a software name for relative competitive-advantage reasons, it can reinforce a market regime where differentiation inside software matters more than category-level growth. That is a negative for mid-tier application vendors without clear workflow lock-in, but potentially positive for the few platform names with stronger switching costs. Second-order, this can widen dispersion within software and keep index-level flows from rescuing weaker fundamentals, especially if rates stay elevated and investors remain allergic to long-duration cash flows.

The contrarian angle is that the market may be over-penalizing software while underestimating how quickly sentiment can reverse if enterprise spending stabilizes and AI-related budgeting shifts improve revenue visibility. Meanwhile, AEIS may be getting ahead of itself if the data-center narrative proves more about order timing than sustained demand; those names can give back sharply if channel checks cool over a 1-2 quarter window. The tradeable setup is therefore a barbell: own the stronger beneficiary with tangible end-market exposure, but fade the weakest software franchises where competitive moat is least defensible.